Authors:
LAU DH
CROWLEY JJ
HAZUKA MB
ALBAIN KS
LEIGH B
FLETCHER WS
LANIER KS
KEISER WL
LIVINGSTON RB
Citation: Dh. Lau et al., SOUTHWEST-ONCOLOGY-GROUP PHASE-II TRIAL OF CONCURRENT CARBOPLATIN, ETOPOSIDE, AND RADIATION FOR POOR-RISK STAGE-III NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(9), 1998, pp. 3078-3081
Authors:
MARGOLIN KA
LIU PY
FLAHERTY LE
SOSMAN JA
WALKER MJ
SMITH JW
FLETCHER WS
WEISS GR
UNGER JM
SONDAK VK
Citation: Ka. Margolin et al., PHASE-II STUDY OF CARMUSTINE, DACARBAZINE, CISPLATIN, AND TAMOXIFEN IN ADVANCED MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 16(2), 1998, pp. 664-669
Citation: Ws. Fletcher et al., RESULTS OF TREATMENT OF INFERIOR VENA-CAVA SYNDROME WITH EXPANDABLE METALLIC STENTS, Archives of surgery, 133(9), 1998, pp. 935-938
Authors:
LUM SS
WOLTERING EA
FLETCHER WS
POMMIER RF
Citation: Ss. Lum et al., CHANGES IN SERUM ESTROGEN-LEVELS IN WOMEN DURING TAMOXIFEN THERAPY, The American journal of surgery, 173(5), 1997, pp. 399-402
Authors:
FLAHERTY LE
LIU PY
MITCHELL MS
FLETCHER WS
WALKER MJ
GOODWIN JW
STEPHENS RL
SONDAK VK
Citation: Le. Flaherty et al., THE ADDITION OF TAMOXIFEN TO DACARBAZINE AND CISPLATIN IN METASTATIC MALIGNANT-MELANOMA - A PHASE-II TRIAL OF THE SOUTHWEST ONCOLOGY GROUP (SWOG-8921), American journal of clinical oncology, 19(2), 1996, pp. 108-113
Authors:
FLETCHER WS
GOODNIGHT JE
PECK JJ
VETTO JT
RYAN JA",MORTON
Citation: Ws. Fletcher et al., SURGICAL RESECTION FOR MELANOMA METASTATIC TO THE GASTROINTESTINAL-TRACT - DISCUSSION, Archives of surgery, 131(9), 1996, pp. 979-980
Authors:
ROULLET JB
XUE H
ROULLET CM
FLETCHER WS
CIPOLLA MJ
HARKER CT
MCCARRON DA
Citation: Jb. Roullet et al., MEVALONATE AVAILABILITY AFFECTS HUMAN AND RAT RESISTANCE VESSEL FUNCTION, The Journal of clinical investigation, 96(1), 1995, pp. 239-244
Authors:
DIACO DS
HAJARIZADEH H
MUELLER CR
FLETCHER WS
POMMIER RF
WOLTERING EA
Citation: Ds. Diaco et al., TREATMENT OF METASTATIC CARCINOID-TUMORS USING MULTIMODALITY THERAPY OF OCTREOTIDE ACETATE INTRAARTERIAL CHEMOTHERAPY, AND HEPATIC ARTERIALCHEMOEMBOLIZATION, The American journal of surgery, 169(5), 1995, pp. 523-528
Authors:
FLETCHER WS
POMMIER RF
WOLTERING EA
MUELLER CR
ASH KO
SMALL KA
Citation: Ws. Fletcher et al., PHARMACOKINETICS AND RESULTS OF DOSE-ESCALATION IN CISPLATIN HYPERTHERMIC ISOLATION LIMB PERFUSION, Annals of surgical oncology, 1(3), 1994, pp. 236-243
Citation: Ws. Fletcher et al., RESULTS OF CISPLATIN HYPERTHERMIC ISOLATION PERFUSION FOR STAGE-IIIA AND STATE-IIIAB EXTREMITY MELANOMA, Melanoma research, 4, 1994, pp. 17-19
Authors:
SONDAK VK
KOPECKY KJ
LIU PY
FLETCHER WS
HARVEY WH
LAUFMAN LR
Citation: Vk. Sondak et al., DIDEMNIN-B IN METASTATIC MALIGNANT-MELANOMA - A PHASE-II TRIAL OF THESOUTHWEST-ONCOLOGY-GROUP, Anti-cancer drugs, 5(2), 1994, pp. 147-150
Authors:
MEYSKENS FL
LIU PY
TUTHILL RJ
SONDAK VK
FLETCHER WS
JEWELL WR
SAMLOWSKI W
BALCERZAK SP
RECTOR DJ
NOYES RD
COSTANZI JJ
Citation: Fl. Meyskens et al., RANDOMIZED TRIAL OF VITAMIN-A VERSUS OBSERVATION AS ADJUVANT THERAPY IN HIGH-RISK PRIMARY MALIGNANT-MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(10), 1994, pp. 2060-2065
Authors:
BARRIE R
WOLTERING EA
HAJARIZADEH H
MUELLER C
URE T
FLETCHER WS
Citation: R. Barrie et al., INHIBITION OF ANGIOGENESIS BY SOMATOSTATIN AND SOMATOSTATIN-LIKE COMPOUNDS IS STRUCTURALLY DEPENDENT, The Journal of surgical research, 55(4), 1993, pp. 446-450
Authors:
WOZNIAK AJ
BLUMENSTEIN BA
CRAWFORD ED
BOILEAU M
RIVKIN SE
FLETCHER WS
Citation: Aj. Wozniak et al., CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL IN THE TREATMENT OF METASTATIC PROSTATE-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Cancer, 71(12), 1993, pp. 3975-3978